Toward understanding insulin fibrillation.

Formation of insulin fibrils is a physical process by which partially unfolded insulin molecules interact with each other to form linear aggregates. Shielding of hydrophobic domains is the main driving force for this process, but formation of intermolecular beta-sheet may further stabilize the fibrillar structure. Conformational displacement of the B-chain C-terminal with exposure of nonpolar, aliphatic core residues, including A2, A3, B11, and B15, plays a crucial role in the fibrillation process. Recent crystal analyses and molecular modeling studies have suggested that when insulin fibrillates this exposed domain interacts with a hydrophobic surface domain formed by the aliphatic residues A13, B6, B14, B17, and B18, normally buried when three insulin dimers form a hexamer. In rabbit immunization experiments, insulin fibrils did not elicit an increased immune response with respect to formation of IgG insulin antibodies when compared with native insulin. In contrast, the IgE response increased with increasing content of insulin in fibrillar form. Strategies and practical approaches to prevent insulin from forming fibrils are reviewed. Stabilization of the insulin hexameric structure and blockage of hydrophobic interfaces by addition of surfactants are the most effective means of counteracting insulin fibrillation.

[1]  N. F. Maclagan,et al.  The Purification and Properties of Insulin. , 1927, The Biochemical journal.

[2]  F. Bischoff,et al.  STUDIES ON INSULIN , 1927 .

[3]  J. Lens The inactivation of insulin solutions. , 1947, The Journal of biological chemistry.

[4]  I. Langmuir,et al.  Pressure-Soluble and Pressure-Displaceable Components of Monolayers of Native and Denatured Proteins , 1940 .

[5]  E. Dodson,et al.  Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer , 1989, Nature.

[6]  E. J. Ambrose,et al.  Infra-red spectroscopic studies of globular protein structure , 1951, Proceedings of the Royal Society of London. Series A. Mathematical and Physical Sciences.

[7]  R. Ratner,et al.  Persistent Cutaneous Insulin Allergy Resulting From High-Molecular-Weight Insulin Aggregates , 1990, Diabetes.

[8]  G. Andrews,et al.  COMPARISON OF WEIGHT REDUCTION WITH METOPROLOL IN TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS , 1985, The Lancet.

[9]  M. Rougvie,et al.  Cross- protein structures. I. Insulin fibrils. , 1972, Biochemistry.

[10]  E J Dodson,et al.  X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. , 1991, Journal of molecular biology.

[11]  K. Irsigler,et al.  Long-Term Continuous Intravenous Insulin Therapy with a Portable Insulin Dosage-regulating Apparatus , 1979, Diabetes.

[12]  E. Perry,et al.  Properties and possible significance of substance P and insulin fibrils , 1981, Neuroscience Letters.

[13]  M. Katakam,et al.  Aggregation of insulin and its prevention by carbohydrate excipients. , 1995, PDA journal of pharmaceutical science and technology.

[14]  J. Brange Stability of insulin : studies on the physical and chemical stability of insulin in pharmaceutical formulation , 1994 .

[15]  R. Porter The reactivity of the iminazole ring in proteins. , 1950, The Biochemical journal.

[16]  B. Diamant,et al.  Histamine Release from Washed Whole Blood , 1982 .

[17]  W V Moore,et al.  Role of aggregated human growth hormone (hGH) in development of antibodies to hGH. , 1980, The Journal of clinical endocrinology and metabolism.

[18]  V. Vigneaud,et al.  THE HEAT PRECIPITATION OF INSULIN , 1933 .

[19]  E. A. Evans,et al.  THE ACTION OF VARIOUS REAGENTS ON INSULIN , 1936 .

[20]  T L Blundell,et al.  The structure of 2Zn pig insulin crystals at 1.5 A resolution. , 1988, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  M. Weiss,et al.  Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition. , 1991, Biochemistry.

[22]  I. Hinberg,et al.  Aggregation of Insulin, Containing Surfactants, in Contact with Different Materials , 1985, Diabetes.

[23]  P. Blackshear,et al.  TREATMENT OF A TYPE II DIABETIC BY A TOTALLY IMPLANTABLE INSULIN INFUSION DEVICE , 1981, The Lancet.

[24]  J. Brange,et al.  Neutral Insulin Solutions Physically Stabilized by Addition of Zn2+ , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[25]  J. Tamada,et al.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Raskin,et al.  Cutaneous Complications of Chronic Continuous Subcutaneous Insulin Infusion Therapy , 1981, Diabetes Care.

[27]  D. Robbins,et al.  Antibodies to Covalent Aggregates of Insulin in Blood of Insulin-Using Diabetic Patients , 1987, Diabetes.

[28]  D. F. Waugh A Fibrous Modification of Insulin. I. The Heat Precipitate of Insulin , 1946 .

[29]  W. McBride,et al.  Factors influencing the immune response. II. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intraperitoneal injection of bovine serum albumin in rabbits. , 1967, Clinical and experimental immunology.

[30]  M. Dathe,et al.  Insulin aggregation in solution. , 2009, International journal of peptide and protein research.

[31]  D. F. Waugh,et al.  Studies of the Nucleation and Growth Reactions of Selected Types of Insulin Fibrils , 1953 .

[32]  S. Pongor,et al.  Preparation of High-Potency, Non-aggregating Insulins Using a Novel Sulfation Procedure , 1983, Diabetes.

[33]  E. H. Mercer,et al.  Electron microscopical observations of fibrous insulin. , 1952, Biochimica et biophysica acta.

[34]  A. Krogh,et al.  The destructive action of heat on insulin solutions. , 1928, The Biochemical journal.

[35]  G. Glenner,et al.  β-PLEATED SHEET FIBRILS A COMPARISON OF NATIVE AMYLOID WITH SYNTHETIC PROTEIN FIBRILS , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  P. Blackshear,et al.  Glycerol Prevents Insulin Precipitation and Interruption of Flow in an Implantable Insulin Infusion Pump , 1983, Diabetes Care.

[37]  R. Bear,et al.  An X-Ray Diffraction Investigation of Selected Types of Insulin Fibrils , 1954 .

[38]  D. F. Waugh A mechanism for the formation of fibrils from protein molecules. , 1957, Journal of cellular physiology. Supplement.

[39]  N. Yu,et al.  Single-crystal Raman spectra of native insulin. Structures of insulin fibrils, glucagon fibrils, and intact calf lens. , 1974, Archives of biochemistry and biophysics.

[40]  J T Finch,et al.  Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences. , 1992, Journal of molecular biology.

[41]  D. Brems,et al.  Equilibrium intermediates in the denaturation of human insulin and two monomeric insulin analogs. , 1994, Biochemistry.

[42]  C. Eddy,et al.  STUDIES ON CRYSTALLINE INSULIN VI. FURTHER CONTRIBUTIONS TO THE QUESTION WHETHER OR NOT CRYSTALLINE INSULIN IS AN ADSORPTION PRODUCT , 1928 .

[43]  A. Klibanov,et al.  Mechanism of insulin aggregation and stabilization in agitated aqueous solutions , 1992, Biotechnology and bioengineering.

[44]  D. F. Waugh,et al.  Protein-protein interactions. , 1954, Advances in protein chemistry.

[45]  Tom L. Blundell,et al.  Insulin: The Structure in the Crystal and its Reflection in Chemistry and Biology by , 1972 .

[46]  J. Brange Galenics of Insulin , 1987 .

[47]  C. Saudek,et al.  Stable Insulin Preparation for Implanted Insulin Pumps: Laboratory and Animal Trials , 1987, Diabetes.

[48]  D. F. Waugh THE LINKAGE OF CORPUSCULAR PROTEIN MOLECULES. I. A FIBROUS MODIFICATION OF INSULIN , 1944 .

[49]  R. Mitra,et al.  Minimization of shaking-induced formation of insoluble aggregates of insulin by cyclodextrins. , 1993, Journal of drug targeting.

[50]  K. Hutchison Assessment of gelling in insulin solutions for infusion pumps , 1985, The Journal of pharmacy and pharmacology.